Hantavirus nucleoprotein (N protein)

The Hantavirus nucleoprotein (N protein) is a critical structural component of hantaviruses, which are responsible for severe diseases such as Hantavirus Pulmonary Syndrome (HPS) and Hemorrhagic Fever with Renal Syndrome (HFRS) [1, 3]. Its primary biological role is the encapsidation of the tripartite negative-sense RNA genome, forming the ribonucleoprotein (RNP) complex necessary for viral stability and replication [2, 4]. Beyond structural duties, the N protein acts as a chaperone for viral RNA, facilitates translation initiation by binding the 5' cap of host mRNAs, and suppresses the host's innate immune response by inhibiting interferon signaling [1, 2]. Because it is the most abundantly expressed protein during infection, it serves as the gold standard for diagnostic serology and is a key candidate for vaccine development [3]. From a therapeutic perspective, the N protein is an attractive target for small-molecule inhibitors designed to block its oligomerization or its interaction with viral RNA [2]. While broad-spectrum antivirals like Ribavirin are sometimes used, they do not specifically target the N protein, leading to a push for more selective inhibitors that can disrupt the RNP assembly process [2, 3]. Challenges in targeting this protein include the high genetic diversity among different hantavirus species and the potential for rapid emergence of resistance mutations [3, 4]. Current research continues to characterize the precise molecular interactions of the N protein to facilitate the design of highly specific antiviral agents [2].

Other names

Nucleocapsid proteinNPHantavirus N proteinNucleoprotein

Inhibition of viral RNA encapsidation and ribonucleoprotein complex formation; interference with viral RNA synthesis and host immune evasion mechanisms.